A personal retrospective on a journey from ground school to commanding a jet, documenting the discipline and milestones required to succeed in the competitive world of aviation. Americans sour on ...

Dushay is an assistant professor of medicine at Harvard Medical School and an attending endocrinologist at Beth Israel Deaconess Medical Center. It makes my head spin to think about how much GLP-1s ...

LANSING, Mich. (WLNS) — Michigan is failing to meet the American Lung Association’s standards for preventing and reducing tobacco use, according to a new report. The American Lung Association`s annual ...

As GLP-1s continue to surge in demand, older patients in your practice may inquire about these medications for their weight-loss efforts. Although they are known to improve conditions such as high ...

Musk could be consolidating his companies. Musk could be consolidating his companies. is a senior reporter covering technology, gaming, and more. He joined The Verge in 2019 after nearly two years at ...

Jan 27 (Reuters) - Enterprise artificial intelligence software provider C3.AI (AI.N), opens new tab is in talks to merge with software company Automation Anywhere, The Information reported on Tuesday, ...

A sizable percentage of people using Novo (NVO) and Lilly’s (LLY) GLP-1 drugs may be able to sustain their weight loss effects even months after discontinuing the popular obesity drugs, Reuters ...

As more continues to be understood about the health benefits associated with GLP-1 drugs, a growing body of science is aiming to answer whether the popular weight-loss medication can help with one of ...

Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will collaborate with the new venture to develop technology to link ...

For women with obesity, GLP-1 medications like Ozempic and Wegovy may help address the metabolic challenges that often intensify during midlife. The hormonal shifts of perimenopause and menopause can ...